Levothyroxine Sodium Tablet
Product Images NDC 0615-8599

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 0615-8599). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Levothyroxine Sodium Tabs 8573 8574 8597 8598 8599 1)

FDA Label Image

Principal Display Panel (Levothyroxine Sodium Tabs 8573 8574 8597 8598 8599 2)

Principal Display Panel (Levothyroxine Sodium Tabs 8573 8574 8597 8598 8599 2)
This is a description of Levothyroxine Sodium tablets with a strength of 25 micrograms (0.025 milligrams). The tablets are packaged and distributed by Amneal and Vangard in Glasgow, Kentucky. The lot number of the tablets is 8573. The storage conditions recommend a temperature range of 20-25°C (68-77°F) with excursions between 15-30°C (59-86°F). The typical dosage information should be reviewed from the package insert for complete prescribing details. The product is intended for institutional use only.*
FDA Label Image

Principal Display Panel (Levothyroxine Sodium Tabs 8573 8574 8597 8598 8599 3)

Principal Display Panel (Levothyroxine Sodium Tabs 8573 8574 8597 8598 8599 3)
This text appears to be a detailed description of a medication called "Levothyroxine Sodium Tablets, USP 50 mcg (0.05 mg)". It includes information such as the National Drug Code (NDC) number, dosage, manufacturer details, storage conditions, and usage instructions. The medication is intended for institutional use only. The text also mentions the trademark of the packaging configuration and provides various NDC numbers associated with the product. It seems to be a comprehensive document related to the specifications and handling of the mentioned medication.*
FDA Label Image

Principal Display Panel (Levothyroxine Sodium Tabs 8573 8574 8597 8598 8599 4)

FDA Label Image

Principal Display Panel (Levothyroxine Sodium Tabs 8573 8574 8597 8598 8599 5)

Principal Display Panel (Levothyroxine Sodium Tabs 8573 8574 8597 8598 8599 5)
This text contains information related to a medication called Levothyroxine Sodium. It provides details such as dosage, storage conditions, and package insert information. The medication is available in tablet form, with various strengths ranging from 58 mcg to 88 mcg. The text also includes details about the manufacturer and packaging of the medication. Additionally, it mentions that the storage conditions should be between 20-25°C (68-77°F) with excursions between 15-30°C (59-86°F). The recommended dosage should be checked in the package insert for full prescribing information.*
FDA Label Image

Principal Display Panel (Levothyroxine Sodium Tabs 8573 8574 8597 8598 8599 6)

FDA Label Image

Principal Display Panel (Levothyroxine Sodium Tabs 8573 8574 8597 8598 8599 7)

FDA Label Image

Principal Display Panel (Levothyroxine Sodium Tabs 8573 8574 8597 8598 8599 8)

Principal Display Panel (Levothyroxine Sodium Tabs 8573 8574 8597 8598 8599 8)
This is a product information sheet for Levothyroxine Sodium tablets, USP 125 mcg. The tablets are indicated for thyroid hormone replacement therapy and the usual dosage should be followed as per the package insert. The storage conditions require a temperature range of 15-30°C (59-86°F). The tablets are packaged by VANGARD in Glasgow, KY. The product is designated for institutional use only.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.